PTEN and breast cancer: Although rare, somatic PTEN mutations have previously been reported in breast cancer [43,44], but they were seen mainly in the basal-like tumors class characterized by a loss of expression of PTEN [45] and more specifically in tumors from patients with BRCA1 mutations [40].